Nox1, 2, 4, 5: Counting out oxidative stress
Open accessAbstract
For decades, oxidative stress has been discussed as a key mechanism of endothelial dysfunction and cardiovascular disease. However, attempts to validate and exploit this hypothesis clinically by supplementing antioxidants have failed. Nevertheless, this does not disprove the oxidative stress hypothesis. As a certain degree of reactive oxygen species (ROS) formation appears to be physiological and beneficial. To reduce oxidative stress therapeutically, two alternative approaches are being developed. One is the repair of key signalling components that are compromised by oxidative stress. These include uncoupled endothelial nitric oxide (NO) synthase and oxidized/heme‐free NO receptor soluble guanylate cyclase. A second approach is to identify and effectively inhibit the relevant source(s) of ROS in a given disease condition. A highly likely target in this context is the family of NADPH oxidases. Animal models, including NOX knockout mice and new pharmacological inhibitors of NADPH oxidases have opened up a new era of oxidative stress research and have paved the way for new cardiovascular therapies. LINKED ARTICLES This article is part of a themed issue on Vascular Endothelium in Health and Disease. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.164.issue‐3
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Apocynin directly scavenges ROS due to its antioxidant capacities.
“Instead, apocynin directly scavenges ROS due to its antioxidant capacities [340,395,396,397,398].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [340]
Apocynin was long considered as a specific Nox2 inhibitor, but several studies have shown that this is not the case.
“Apocynin was long considered as specific Nox2 inhibitor. However, several studies have shown that this is indeed not the case.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [340]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · see citing works
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705 · see citing works
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,611 · see citing works
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577 · see citing works
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,407 · see citing works
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275 · see citing works
Primary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
Stampfer, M. J., Hu, F. B., Manson, J. E., Rimm, E. B., & Willett, W. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430103 · Cited by 1,794 · see citing works
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660 · see citing works
Landmesser, U., Dikalov, S., Price, S. R., McCann, L. A., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14172 · Cited by 1,652 · see citing works
Antioxidants prevent health-promoting effects of physical exercise in humans
Ristow, M., Zarse, K., Oberbach, A., Klöting, N., Birringer, M., Kiehntopf, M., Stumvoll, M., Kahn, C. R., & Blüher, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903485106 · Cited by 1,582 · see citing works
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish
Niethammer, P., Grabher, C., Look, A. T., & Mitchison, T. J. (2009) · Nature · doi:10.1038/nature08119 · Cited by 1,541 · see citing works
Treasure, C. B., Klein, J., Weintraub, W. S., Talley, J., Stillabower, M., Kosinski, A. S., Zhang, J., Boccuzzi, S., Cedarholm, J. C., & Alexander, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320801 · Cited by 1,335 · see citing works
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,192 · see citing works
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181 · see citing works
Tadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,096 · see citing works
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083 · see citing works
&NA; (1996) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199605000-00005 · Cited by 1,070 · see citing works
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031 · see citing works
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,016 · see citing works
Lipid peroxidation: Physiological levels and dual biological effects
Niki, E. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.032 · Cited by 1,006 · see citing works
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
O’Driscoll, G., Green, D., & Taylor, R. R. (1997) · Circulation · doi:10.1161/01.cir.95.5.1126 · Cited by 952 · see citing works
Erectile Dysfunction and Subsequent Cardiovascular Disease
Thompson, I. M. (2005) · JAMA · doi:10.1001/jama.294.23.2996 · Cited by 883 · see citing works
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5
Cheng, G., Cao, Z., Xu, X., Meir, E. G. V., & Lambeth, J. D. (2001) · Gene · doi:10.1016/s0378-1119(01)00449-8 · Cited by 820 · see citing works
Ristow, M., & Zarse, K. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.03.014 · Cited by 789 · see citing works
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772 · see citing works
Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene
Riemersma, R. A., Wood, D. A., Oliver, M. F., Elton, R. A., Macintyre, C. C. A., & GEY, K. F. (1991) · The Lancet · doi:10.1016/0140-6736(91)93327-6 · Cited by 771 · see citing works
Evgenov, O. V., Pacher, P., Schmidt, P. M., Haskó, G., Schmidt, H. H. H. W., & Stasch, J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2038 · Cited by 748 · see citing works
Self-citationTherapeutic Targeting of Mitochondrial Superoxide in Hypertension
Dikalova, A., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L. A., Lewis, W., Harrison, D. G., & Dikalov, S. (2010) · Circulation Research · doi:10.1161/circresaha.109.214601 · Cited by 737 · see citing works
Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant
Heumüller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H. H. H. W., Busse, R., Schröder, K., & Brandes, R. P. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100214 · Cited by 735 · see citing works
Self-citationOxidative Stress and Cardiovascular Injury
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093661.90582.c4 · Cited by 720 · see citing works
Doughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008) · Circulation Research · doi:10.1161/circresaha.107.162800 · Cited by 710 · see citing works
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687 · see citing works
Zang, M., Xu, S., Maitland, K. A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T. J., & Cohen, R. A. (2006) · Diabetes · doi:10.2337/db05-1188 · Cited by 663 · see citing works
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630 · see citing works
A Ca2+-activated NADPH Oxidase in Testis, Spleen, and Lymph Nodes
Bánfi, B., Molnár, G., Maturana, A., Steger, K., Hegedûs, B., Demaurex, N., & Krause, K.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103034200 · Cited by 622 · see citing works
Rey, F. E., Cifuentes-Pagano, E., Kiarash, A., Quinn, M. T., & Pagano, P. J. (2001) · Circulation Research · doi:10.1161/hh1701.096037 · Cited by 606 · see citing works
Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F., & Busse, R. (2000) · Circulation Research · doi:10.1161/01.res.87.1.26 · Cited by 598 · cited 2× · see citing works
“Nevertheless, it can be said with some certainty that NOX2 is not only present in leukocytes, but also in endothelial cells (Gorlach et al., 2000; Bedard and Krause, 2007), fibroblasts (Chamseddine and Miller, 2003) and cardiac myocytes (Nabeebaccus et al.”
NADPH Oxidases: Functions and Pathologies in the Vasculature
Lassègue, B., & Griendling, K. K. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181610 · Cited by 592 · see citing works
Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590 · see citing works
Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo
Waßmann, S., Laufs, U., Müller, K., Konkol, C., Ahlbory, K., Bäumer, A. T., Linz, W., Böhm, M., & Nickenig, G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104081 · Cited by 589 · see citing works
O’Donnell, V. B., Tew, D. G., Jones, O. T. G., & ENGLAND, P. J. (1993) · Biochemical Journal · doi:10.1042/bj2900041 · Cited by 588 · see citing works
Free radicals in cerebral ischemia.
Flamm, E. S., Demopoulos, H. B., Seligman, M. L., Poser, R. G., & Ransohoff, J. (1978) · Stroke · doi:10.1161/01.str.9.5.445 · Cited by 577 · see citing works
Zhao, H., Joseph, J., Fales, H. M., Sokoloski, E. A., Levine, R. L., Vasquez-Vivar, J., & Kalyanaraman, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501719102 · Cited by 576 · see citing works
Khaw, K., Bingham, S. A., Welch, A. A., Luben, R., Wareham, N. J., Oakes, S., & Day, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04128-3 · Cited by 576 · see citing works
Measurement of Reactive Oxygen Species in Cardiovascular Studies
Dikalov, S., Griendling, K. K., & Harrison, D. G. (2007) · Hypertension · doi:10.1161/01.hyp.0000258594.87211.6b · Cited by 532 · see citing works
Healthy Living Is the Best Revenge
Ford, E. S., Bergmann, M. M., Kröger, J., Schienkiewitz, A., Weikert, C., & Boeing, H. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.237 · Cited by 514 · see citing works
Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant
Bowry, V. W., Ingold, K. U., & Stocker, R. (1992) · Biochemical Journal · doi:10.1042/bj2880341 · Cited by 511 · see citing works
Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.109.213116 · Cited by 506 · see citing works
Primary Prevention of Stroke by Healthy Lifestyle
Chiuve, S. E., Rexrode, K. M., Spiegelman, D. L., Logroscino, G., Manson, J. E., & Rimm, E. B. (2008) · Circulation · doi:10.1161/circulationaha.108.781062 · Cited by 496 · see citing works
Subcellular localization of Nox4 and regulation in diabetes
Block, K. L., Gorin, Y. C., & Abboud, H. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906805106 · Cited by 476 · see citing works
Nox1 Is Involved in Angiotensin II–Mediated Hypertension: A Study in Nox1-Deficient Mice
Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanishi, K., Miyazaki, M., Matsubara, H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.573709 · Cited by 470 · see citing works
Stasch, J., Schmidt, P. M., Nedvetsky, P. I., Nedvetskaya, T. Y., Kumar, A. H. S., Meurer, S., Deile, M., Taye, A., Knorr, A., Lapp, H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28371 · Cited by 456 · see citing works
Self-citationKleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000479 · Cited by 447 · see citing works
Self-citationDikalova, A., Clempus, R., Lassègue, B., Cheng, G., McCoy, J., Dikalov, S., Martin, A. S., Lyle, A., Weber, D. S., Weiss, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.538934 · Cited by 438 · see citing works
Self-citationThe Antioxidants and Pro-Antioxidants Network: An Overview
Vertuani, S., Angusti, A., & Manfredini, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384655 · Cited by 438 · see citing works
Rajasekaran, N. S., Connell, P., Christians, E. S., Yan, L.-J., Taylor, R. P., Orosz, A., Zhang, X. Q., Stevenson, T. J., Peshock, R. M., Leopold, J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.06.044 · Cited by 437 · see citing works
Lipid peroxidation cannot be used as a universal criterion of oxidative stress
Dotan, Y. (2003) · Progress in Lipid Research · doi:10.1016/j.plipres.2003.10.001 · Cited by 434 · see citing works
Methods for detection and measurement of hydrogen peroxide inside and outside of cells
Rhee, S. G., Chang, T.-S., Jeong, W., & Kang, D. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0082-3 · Cited by 433 · see citing works
Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension
Schulz, E., Jansen, T., Wenzel, P., Daiber, A., & Münzel, T. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1989 · Cited by 430 · see citing works
Reactive oxygen species as mediators of angiotensin II signaling
Griendling, K. K., & Ushio‐Fukai, M. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00136-1 · Cited by 417 · see citing works
Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking
Lykkesfeldt, J. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.01.028 · Cited by 416 · see citing works
Sedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., Page, P., Kennedy, C. R. J., Burns, K. D., Touyz, R. M., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00028.2010 · Cited by 396 · see citing works
Sorescu, G. P., Song, H. W., Tressel, S. L., Hwang, J., Dikalov, S., Smith, D. A., Boyd, N. L., Platt, M. O., Lassegue, B. P., Griendling, K. K., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000145728.22878.45 · Cited by 379 · see citing works
Mozaffarian, D., Kamineni, A., Carnethon, M., Djoussé, L., Mukamal, K. J., & Siscovick, D. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.21 · Cited by 358 · see citing works
Endothelial Function in Hypertension
McIntyre, M., Bohr, D. F., & Dominiczak, A. F. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.539 · Cited by 355 · see citing works
Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase
Walder, C. E., Green, S. P., Darbonne, W. C., Mathias, J., Rae, J., Dinauer, M. C., Curnutte, J. T., & Thomas, G. R. (1997) · Stroke · doi:10.1161/01.str.28.11.2252 · Cited by 349 · see citing works
Reactive oxygen species in hypertension*1An update
Lassegue, B. P. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.02.004 · Cited by 341 · see citing works
Decreased blood pressure in NOX1‐deficient mice
Gavazzi, G., Banfi, B., Deffert, C., Fiette, L., Schappi, M., Herrmann, F., & Krause, K.-H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.049 · Cited by 321 · see citing works
Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people
Gale, C., Martyn, C., Winter, P., & Cooper, C. (1995) · British medical journal · doi:10.1136/bmj.310.6994.1563 · Cited by 316 · see citing works
Inhibition of NADPH Oxidase is Neuroprotective after Ischemia—Reperfusion
Chen, H., Song, Y. S., & Chan, P. H. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.47 · Cited by 286 · see citing works
Detection of Superoxide in Vascular Tissue
Münzel, T. F., Afanasʹev, I. B., Kleschyov, A. L., & Harrison, D. G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000034022.11764.ec · Cited by 281 · see citing works
Guzik, T. J., Chen, W., Gongora, M. C., Guzik, B., Lob, H. E., Mangalat, D., Hoch, N., Dikalov, S., Rudzinski, P., Kapelak, B., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.063 · Cited by 281 · see citing works
Glorioso, N., Troffa, C., Filigheddu, F., Dettori, F., Soro, A., Parpaglia, P. P., Collatina, S., & Pahor, M. (1999) · Hypertension · doi:10.1161/01.hyp.34.6.1281 · Cited by 278 · see citing works
Wingler, K., Wünsch, S., Kreutz, R. H., Rothermund, L., Paul, M., & Schmidt, H. H. H. W. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00727-4 · Cited by 269 · see citing works
Self-citationNADPH oxidases in cardiovascular disease
Brandes, R. P., Weißmann, N., & Schröder, K. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.030 · Cited by 266 · see citing works
Stephens, J. W., Khanolkar, M., & Bain, S. C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.006 · Cited by 262 · see citing works
Fink, B., Laude, K. M., McCann, L. A., Doughan, A. K., Harrison, D. G., & Dikalov, S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00028.2004 · Cited by 259 · see citing works
TENFREYHAUS, H., HUNTGEBURTH, M., WINGLER, K., SCHNITKER, J., BAUMER, A., VANTLER, M., BEKHITE, M., WARTENBERG, M., SAUER, H., & ROSENKRANZ, S. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.022 · Cited by 259 · see citing works
Self-citationNyyssonen, K., Parviainen, M. T., Salonen, R., Tuomilehto, J. O., & Salonen, J. T. (1997) · BMJ · doi:10.1136/bmj.314.7081.634 · Cited by 256 · see citing works
Tsunekawa, T., Hayashi, T., Kano, H., Sumi, D., Matsui‐Hirai, H., Thakur, N. K., Egashira, K., & Iguchi, A. (2001) · Circulation · doi:10.1161/hc2901.094094 · Cited by 256 · see citing works
gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular Hypertension
Jung, O., Schreiber, J. G., Geiger, H., Pedrazzini, T., Busse, R., & Brandes, R. P. (2004) · Circulation · doi:10.1161/01.cir.0000124223.00113.a4 · Cited by 255 · see citing works
NOX5 variants are functionally active in endothelial cells
BelAiba, R. S., Djordjevic, T., Petry, A., Diemer, K., Bonello, S., Banfi, B., Hess, J., Pogrebniak, A., Bickel, C., & Görlach, A. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.10.054 · Cited by 255 · see citing works
Cardounel, A. J., Cui, H., Samouilov, A., Johnson, W., Kearns, P. N., Tsai, A.-L., Berka, V., & Zweier, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603606200 · Cited by 246 · see citing works
Small-Molecule NOX Inhibitors: ROS-Generating NADPH Oxidases as Therapeutic Targets
Jaquet, V., Scapozza, L., Clark, R. A., Krause, K. H., & Lambeth, J. D. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2585 · Cited by 243 · see citing works
Comparative pharmacology of chemically distinct nadph oxidase inhibitors
Wind, S., Beuerlein, K., Eucker, T., Müller, H., Scheurer, P., Armitage, M., Ho, H., Schmidt, H., & Wingler, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00920.x · Cited by 241 · see citing works
Self-citationSelemidis, S., Sobey, C. G., Wingler, K., Schmidt, H. H. H. W., & Drummond, G. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.005 · Cited by 241 · see citing works
Self-citationNADPH oxidase 4 is an oncoprotein localized to mitochondria
Graham, K., Kulawiec, M., Owens, K. M., Li, X., Desouki, M. M., Chandra, D., & Singh, K. K. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.3.12207 · Cited by 236 · see citing works
Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond
Böger, R. H. (2006) · Annals of Medicine · doi:10.1080/07853890500472151 · Cited by 236 · see citing works
Novel NAD(P)H oxidases in the cardiovascular system: Table 1
Griendling, K. K. (2004) · Heart · doi:10.1136/hrt.2003.029397 · Cited by 213 · see citing works
Carotenoids, vitamins C and E, and mortality in an elderly population.
Sahyoun, N. R., Jacques, P. F., & Russell, R. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008957 · Cited by 212 · see citing works
NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries
Miller, A. A., Drummond, G. R., Schmidt, H. H. H. W., & Sobey, C. G. (2005) · Circulation Research · doi:10.1161/01.res.0000189301.10217.87 · Cited by 211 · cited 5× · see citing works
“Likewise, vitamin E supplements can no longer be considered safe for the general population (Dotan et al., 2009; Miller et al., 2005b; Miller and Guallar, 2009).”
InfluentialSelf-citationNovel Mechanism of Activation of NADPH Oxidase 5
Jagnandan, D., Church, J. E., Banfi, B., Stuehr, D. J., Marrero, M. B., & Fulton, D. J. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608966200 · Cited by 210 · see citing works
Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Aldieri, E., Riganti, C., Polimeni, M., Gazzano, E., Lussiana, C., Campia, I., & Ghigo, D. (2008) · Current Drug Metabolism · doi:10.2174/138920008786049285 · Cited by 201 · see citing works
Majander, A. S., Finel, M., & Wikström, M. K. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31926-9 · Cited by 200 · see citing works
BiP/Kar2p serves as a molecular chaperone during carboxypeptidase Y folding in yeast.
Simons, J. F., Ferro‐Novick, S., Rose, M. D., & Helenius, A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.1.41 · Cited by 199 · see citing works
Diatchuk, V., Lotan, O., Koshkin, V., Wikstroem, P., & Pick, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13292 · Cited by 195 · see citing works
Auch–Schwelk, W., Katušić, Z. S., & Vanhoutte, P. M. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.859 · Cited by 194 · see citing works
Gianni, D., Taulet, N., Zhang, H., DerMardirossian, C., Kister, J., Martinez, L., Roush, W. R., Brown, S. J., Bokoch, G. M., & Rosen, H. (2010) · ACS Chemical Biology · doi:10.1021/cb100219n · Cited by 192 · see citing works
Using Isoprostanes as Biomarkers of Oxidative Stress: Some Rarely Considered Issues
Halliwell, B. B., & Lee, J. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2934 · Cited by 191 · see citing works
Mittendorf, J., Weigand, S., Alonso‐Alija, C., Bischoff, E., Feurer, A., Gerisch, M., Kern, A., Knorr, A., Lang, D. H., Muenter, K., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900014 · Cited by 189 · see citing works
Vitamin C status and mortality in US adults
Loria, C. M., Klag, M. J., Caulfield, L. E., & Whelton, P. K. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.1.139 · Cited by 188 · see citing works
Gotoh, N., & Niki, E. (1992) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(92)90054-x · Cited by 188 · see citing works
Thomson, L., Trujillo, M., Telleri, R., & Radi, R. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1321 · Cited by 186 · see citing works
Shi, J. N., Ross, C. R., Leto, T. L., & Blecha, F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6014 · Cited by 185 · see citing works
Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012
Daiber, A., August, M., Baldus, S. E., Wendt, M., Oelze, M. W., Sydow, K., Kleschyov, A. L., & Münzel, T. F. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.012 · Cited by 184 · see citing works
Wind, S., Beuerlein, K., Armitage, M. E., Taye, A., Kumar, A. H. S., Janowitz, D., Neff, C., Shah, A. M., Wingler, K., & Schmidt, H. H. H. W. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.149187 · Cited by 181 · see citing works
Self-citationMeasurement of total antioxidant capacity
Young, I. S. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.5.339 · Cited by 180 · see citing works
Dikalova, A. E., Góngora, M. C., Harrison, D. G., Lambeth, J. D., Dikalov, S., & Griendling, K. K. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00242.2010 · Cited by 179 · see citing works
Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells
Vejražka, M., MICEK, R., & Štípek, S. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.12.008 · Cited by 173 · see citing works
Galle, J., Zabel, U., Hübner, U., Hatzelmann, A., Wagner, B., Wanner, C., & Schmidt, H. H. H. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702495 · Cited by 173 · see citing works
Self-citationNox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells
Jay, D. B., Papaharalambus, C. A., Seidel-Rogol, B., Dikalova, A. E., Lassègue, B., & Griendling, K. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.024 · Cited by 166 · see citing works
Vecchione, C., & Brandes, R. P. (2002) · Circulation Research · doi:10.1161/01.res.0000028004.76218.b8 · Cited by 161 · see citing works
Li, S. H., Shin, D. H., Chun, Y.-S., Lee, M. K., Kim, M.-S., & Park, J.-W. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0074 · Cited by 160 · see citing works
Reactive Oxygen Species, NADPH Oxidases, and Hypertension
Datla, S. R., & Griendling, K. K. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.142422 · Cited by 154 · see citing works
Turning Back the Clock: Adopting a Healthy Lifestyle in Middle Age
King, D. E., Mainous, A. G., & Geesey, M. E. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.09.020 · Cited by 151 · see citing works
Phosphodiesterase inhibitors for the treatment of pulmonary hypertension
Wilkins, M. R., Wharton, J., Grimminger, F., & Ghofrani, H. A. (2008) · European Respiratory Journal · doi:10.1183/09031936.00124007 · Cited by 151 · see citing works
Zielonka, J., Hardy, M., & Kalyanaraman, B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.031 · Cited by 150 · see citing works
Trotter, E. W., & Grant, C. M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03216.x · Cited by 146 · see citing works
NADPH Oxidase Inhibitors: New Antihypertensive Agents?
Williams, H. C., & Griendling, K. K. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318063e820 · Cited by 146 · see citing works
Zhang, Y., Griendling, K. K., Dikalova, A., Owens, G. K., & Taylor, W. R. (2005) · Hypertension · doi:10.1161/01.hyp.0000182660.74266.6d · Cited by 141 · see citing works
NADPH oxidases and cardiac remodelling
Nabeebaccus, A., Zhang, M., & Shah, A. M. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9186-2 · Cited by 138 · see citing works
Rizvi, A. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a4158c · Cited by 137 · see citing works
Gudmundsson, G. H., Magnússon, K. P., Chowdhary, B. P., Johansson, M., Andersson, L., & Boman, H. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7085 · Cited by 125 · see citing works
Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells
Stielow, C., Catar, R. A., Müller, G. M., Wingler, K., Scheurer, P., Schmidt, H. H. H. W., & Morawietz, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.114 · Cited by 125 · see citing works
Self-citationJackman, K. A., Miller, A. A., Silva, T. M. D., Crack, P. J., Drummond, G. R., & Sobey, C. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00073.x · Cited by 120 · see citing works
Guzik, T. J., Sadowski, J., Kapelak, B., Jopek, A., Rudziński, P., Pillai, R. G., Korbut, R., & Channon, K. M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000139011.94634.9d · Cited by 119 · see citing works
S17834, a New Inhibitor of Cell Adhesion and Atherosclerosis That Targets NADPH Oxidase
Cayatte, A. J., Rupin, A., Oliver-Krasinski, J. M., Maitland, K. A., Sansilvestri, P., Boussard, M.-F., Wierzbicki, M., Verbeuren, T. J., & Cohen, R. A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096723 · Cited by 116 · see citing works
Hydrogen peroxide as an endothelium-derived hyperpolarizing factor
Shimokawa, H. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0790-8 · Cited by 115 · see citing works
Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice
Bhandarkar, S. S., Jaconi, M. E., Fried, L. E., Bonner, M. Y., Lefkove, B., Govindarajan, B., Perry, B. N., Parhar, R., MacKelfresh, J. B., Sohn, A. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33877 · Cited by 114 · see citing works
Zhang, X., Min, X., Li, C., Benjamin, I. J., Qian, B., Zhang, X., Ding, Z., Gao, X., Yao, Y., Ma, Y., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147066 · Cited by 114 · see citing works
Tetrahydrobiopterin Inhibits Monomerization and Is Consumed during Catalysis in Neuronal NO Synthase
Reif, A., Fröhlich, L. G., Kotsonis, P., Frey, A., Bömmel, H. M., Schmidt, H. H. H. W., Wink, D. A., & Pfleiderer, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24921 · Cited by 113 · see citing works
Self-citationDhamrait, S. S. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.01.007 · Cited by 112 · see citing works
Paradoxical Activation of Endothelial Nitric Oxide Synthase by NADPH Oxidase
Zhang, Q., Malik, P., Pandey, D., Gupta, S. A., Jagnandan, D., de Chantemèle, E. J. B., Bánfi, B., Marrero, M. B., Rudic, R. D., Stepp, D. W., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.168278 · Cited by 107 · see citing works
Meurer, S., Pioch, S., Pabst, T., Opitz, N., Schmidt, P. M., Beckhaus, T., Wagner, K., Matt, S., Gegenbauer, K., Geschka, S., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.198234 · Cited by 107 · see citing works
Self-citationMelichar, V. O., Behr‐Roussel, D., Zabel, U., UTTENTHAL, L. O., Rodrigo, J., Rupin, A., Verbeuren, T. J., Kumar, A. H. S., & Schmidt, H. H. H. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405509101 · Cited by 102 · see citing works
Self-citationSingh, R. B., Ghosh, S., Niaz, M. A., Singh, R., Beegum, R., Chibo, H., Shoumin, Z., & Postiglione, A. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80348-8 · Cited by 101 · see citing works
Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition
Chen, W., Pendyala, S., Natarajan, V., Garcia, J. G. N., & Jacobson, J. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00428.2007 · Cited by 100 · see citing works
Reduced NAD(P)H Oxidase in Low Renin Hypertension
Zhou, M.-S., Schulman, I. H., Pagano, P. J., Jaimes, E. A., & Raij, L. R. (2005) · Hypertension · doi:10.1161/01.hyp.0000197182.65554.c7 · Cited by 97 · see citing works
Lange, S., Heger, J., Euler, G., Wartenberg, M., Piper, H. M., & Sauer, H. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn258 · Cited by 96 · see citing works
Nishiyama, A., Yoshizumi, M., Hitomi, H., Kagami, S., Kondo, S., Miyatake, A., Fukunaga, M., Tamaki, T., Kiyomoto, H., Kohno, M., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000108523.02100.e0 · Cited by 95 · see citing works
NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin
Tirone, F., & Cox, J. A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.047 · Cited by 94 · see citing works
Vendrov, A. E., Madamanchi, N. R., Niu, X.-L., Molnar, K., Runge, M., Szyndralewiez, C., Page, P., & Runge, M. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143917 · Cited by 93 · see citing works
NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice
Kahles, T., Kohnen, A., Heumueller, S., Rappert, A., Bechmann, I., Liebner, S., Wittko, I. M., Neumann-Haefelin, T., Steinmetz, H., Schroeder, K., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.023 · Cited by 91 · see citing works
Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition
Schluter, T., Steinbach, A. C., Steffen, A., Rettig, R., & Grisk, O. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn185 · Cited by 90 · see citing works
The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress
Riganti, C., Costamagna, C., Bosìa, A., & Ghigo, D. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.07.011 · Cited by 87 · see citing works
Angiotensin II and NADPH Oxidase Increase ADMA in Vascular Smooth Muscle Cells
Luo, Z., Teerlink, T., Griendling, K. K., Aslam, S., Welch, W. J., & Wilcox, C. S. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.152959 · Cited by 83 · see citing works
Phenothiazine: The Parent Molecule
Mitchell, S. C. (2006) · Current Drug Targets · doi:10.2174/138945006778226552 · Cited by 82 · see citing works
Settergren, M., Böhm, F., Malmström, R. E., Channon, K. M., & Pernow, J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.034 · Cited by 81 · see citing works
cGMP: Generators, Effectors and Therapeutic Implications
Schmidt, H. H. H. W., Hofmann, F. B., & Stasch, J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68964-5 · Cited by 79 · see citing works
Self-citationVanhoutte, P. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.190215 · Cited by 75 · see citing works
gp91phox Contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells
Chamseddine, A. H., & Miller, F. J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2003 · Cited by 75 · see citing works
Hydrogen peroxide is an endothelium‐dependent contracting factor in rat renal artery
Gao, Y., & Lee, R. M. K. W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706423 · Cited by 73 · see citing works
McCann, S., Dusting, G. J., & Roulston, C. L. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21700 · Cited by 72 · see citing works
Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen
Didion, S. P., Ryan, M. J., Baumbach, G. L., Sigmund, C. D., & Faraci, F. M. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00079.2002 · Cited by 68 · see citing works
Biomarkers of Inflammation and Oxidative Stress in Atherosclerosis
Uno, K., & Nicholls, S. J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.57 · Cited by 65 · see citing works
Hoffmann, L., Schmidt, P., Keim, Y., Schaefer, S., Schmidt, H. H. H. W., & Stasch, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00263.x · Cited by 64 · see citing works
Self-citationPro-oxidant activity of apocynin radical
Castor, L. R. G., Locatelli, K. A., & Ximenes, V. F. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.010 · Cited by 63 · see citing works
Kotsonis, P., Fröhlich, L. G., SHUTENKO, Z., Horejsi, R., Pfleiderer, W., & Schmidt, H. H. H. W. (2000) · Biochemical Journal · doi:10.1042/bj3460767 · Cited by 62 · see citing works
Self-citationOpitz, N., Drummond, G. R., Selemidis, S., Meurer, S., & Schmidt, H. H. H. W. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.003 · Cited by 60 · see citing works
Self-citationDotan, Y., Pinchuk, I., Lichtenberg, D. A., & Leshno, M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178699 · Cited by 60 · see citing works
Zanfolin, M., Faro, R., de Araújo, E. G., Guaraldo, A. M. A., Antunes, E., & Nucci, G. D. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000210071.54828.9b · Cited by 56 · see citing works
Small-Molecule Inhibitors of NADPH Oxidase 4
Borbély, G., Szabadkai, I., Horváth, Z., Markó, P., Varga, Z. V., Breza, N., Baska, F., Vántus, T., Huszár, M., Geiszt, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1004368 · Cited by 53 · see citing works
Tsai, M.-H., & Jiang, M. J. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-67 · Cited by 51 · see citing works
Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress
Zhou, Z., Pyriochou, A., Kotanidou, A. N., Dalkas, G. A., van Eickels, M., Spyroulias, G. A., Roussos, C., & Papapetropoulos, A. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.51.2008 · Cited by 50 · see citing works
Tazzeo, T., Worek, F., & Janssen, L. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00394.x · Cited by 42 · see citing works
Wang, P., Tang, F., Li, R., Zhang, H., Chen, S., Liu, P., & Huang, H. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.016 · Cited by 40 · see citing works
Imamura, F., Jacques, P. F., Herrington, D. M., Dallal, G. E., & Lichtenstein, A. H. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27576 · Cited by 39 · see citing works
Kirsch, M., Kemp‐Harper, B. K., Weißmann, N., Grimminger, F., & Schmidt, H. H. H. W. (2007) · The FASEB Journal · doi:10.1096/fj.06-7526com · Cited by 34 · see citing works
Self-citationPark, Y. M., Lim, B. H., Touyz, R. M., & Park, J. B. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.6.1039 · Cited by 34 · see citing works
Fujii, A., Nakano, D., Katsuragi, M., Ohkita, M., Takaoka, M., Ohno, Y., & Matsumura, Y. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.039 · Cited by 32 · see citing works
Effects of the sGC Stimulator BAY 41-2272 Are Not Mediated by Phosphodiesterase 5 Inhibition
Bischoff, E., & Stasch, J. (2004) · Circulation · doi:10.1161/01.cir.0000142209.28862.12 · Cited by 32 · see citing works
Schluter, T., Zimmermann, U., Protzel, C., Miehe, B., Klebingat, K.-J., Rettig, R., & Grisk, O. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp346 · Cited by 27 · see citing works
Schmidt, H. H. H. W., Hofmann, F. B., & Stasch, J. (2009) · PubMed · Cited by 26 · see citing works
Self-citationKawano, H., & Yano, K. (2006) · Circulation Journal · doi:10.1253/circj.70.1116 · Cited by 20 · see citing works
Methods to Evaluate the Pharmacology of Oral Antiplatelet Drugs
Weber, A., Adamzik, M., Bachmann, H. S., Görlinger, K., Grandoch, M., Leineweber, K., Müller-Beißenhirtz, H., Wenzel, F., & Naber, C. K. (2008) · Herz · doi:10.1007/s00059-008-3132-2 · Cited by 18 · see citing works
Vitamin E supplementation: what's the harm in that?
Miller, E. R., & Güallar, E. (2009) · Clinical Trials · doi:10.1177/1740774509103248 · Cited by 10 · see citing works
Regulation of Adhesion Molecules: A New Target for the Treatment of Chronic Venous Insufficiency
Verbeuren, T. J., Bouskela, E., Cohen, R. A., & Vanhoutte, P. M. (2000) · Microcirculation · doi:10.1111/j.1549-8719.2000.tb00150.x · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899 · see citing works
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633 · see citing works
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 576 · see citing works
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 546 · see citing works
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521 · see citing works
Self-citationM1 and M2 Macrophages: The Chicken and the Egg of Immunity
Mills, C. D., & Ley, K. F. (2014) · Journal of Innate Immunity · doi:10.1159/000364945 · Cited by 401 · see citing works
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Scheurer, P., Rob Hermans, J. J., Schiffers, P., Ho, H., Wingler, K., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1010-9 · Cited by 371 · see citing works
Self-citationNADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.132159 · Cited by 386 · see citing works
Self-citationJha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352 · see citing works
Self-citationEndothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond, G. R., & Sobey, C. G. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.012 · Cited by 315 · see citing works
Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension
Li, Q., Youn, J.-Y., & Cai, H. “. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000587 · Cited by 237 · see citing works
Targeting NADPH oxidases in vascular pharmacology
Schramm‐Luc, A., Matusik, P. T., Osmenda, G., & Guzik, T. J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.012 · Cited by 229 · see citing works
Inducible nitric oxide synthase: Good or bad?
Lind, M., Hayes, A., Caprnda, M., Petrovic, D., Rodrigo, L., Kruzliak, P., & Zulli, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.036 · Cited by 229 · see citing works
Redox signaling in cardiovascular health and disease
Madamanchi, N. R., & Runge, M. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.001 · Cited by 223 · see citing works
NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury
Kleikers, P. W. M., Wingler, K., Hermans, J. J. R., Diebold, I., Altenhöfer, S., Radermacher, K. A., Janssen, B. J., Görlach, A., & Schmidt, H. H. H. W. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0963-3 · Cited by 172 · see citing works
Self-citationDaiber, A., & Münzel, T. F. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6376 · Cited by 167 · see citing works
NADPH oxidase family proteins: signaling dynamics to disease management
Begum, R., Thota, S., Abdulkadir, A. S., Kaur, G., Bagam, P., & Batra, S. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00858-1 · Cited by 148 · see citing works
Neuroprotection After Stroke by Targeting NOX4 As a Source of Oxidative Stress
Radermacher, K. A., Wingler, K., Langhauser, F., Altenhöfer, S., Kleikers, P. W. M., Hermans, J. J. R., de Angelis, M. H., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4797 · Cited by 147 · see citing works
Self-citationRoze, L. V., Chanda, A., Wee, J., Awad, D. W., & Linz, J. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253468 · Cited by 144 · see citing works
NADPH oxidases as therapeutic targets in ischemic stroke
Kahles, T., & Brandes, R. P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1011-8 · Cited by 133 · see citing works
Natural Compounds as Modulators of NADPH Oxidases
Maraldi, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/271602 · Cited by 132 · see citing works
On the Clinical Pharmacology of Reactive Oxygen Species
Casas, A. I., Nogales, C., Mucke, H. A., Petraina, A., Cuadrado, A., Rojo, A. I., Ghezzi, P., Jaquet, V., Augsburger, F., Dufrasne, F., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019422 · Cited by 128 · see citing works
Self-citationWhich NADPH Oxidase Isoform Is Relevant for Ischemic Stroke? The Case for Nox 2
Kahles, T., & Brandes, R. P. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4721 · Cited by 125 · see citing works
NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy
Wilkinson‐Berka, J. L., Deliyanti, D., Rana, I., Miller, A. G., Agrotis, A., Armani, R., Szyndralewiez, C., Wingler, K., Touyz, R. M., Cooper, M. E., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5357 · Cited by 123 · see citing works
Self-citationCheng, Y., Song, Y., Chen, H., Li, Q., Gao, Y. Z., Lu, G., & Luo, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5005136 · Cited by 122 · see citing works
Updates of reactive oxygen species in melanoma etiology and progression
Liu, F., Dellinger, R. W., & Meyskens, F. L. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.007 · Cited by 116 · see citing works
Bone targeting antioxidative nano-iron oxide for treating postmenopausal osteoporosis
Zheng, L., Zhuang, Z., Li, Y., Shi, T., Fu, K., Yan, W., Zhang, L., Wang, P., Li, L., & Jiang, Q. Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.012 · Cited by 109 · see citing works
Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond
Daiber, A., Hahad, O., Andreadou, I., Steven, S., Daub, S., & Münzel, T. F. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101875 · Cited by 107 · see citing works
Meng, X., Wang, M., Wang, X., Sun, G., Ye, J., Xu, H., & Sun, X. (2014) · Free Radical Research · doi:10.3109/10715762.2014.911853 · Cited by 106 · see citing works
Yu, G., Liang, Y. S., Huang, Z., Jones, D. W., Pritchard, K. A., & Zhang, H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0583-x · Cited by 103 · see citing works
Teixeira-Santos, L., Albino‐Teixeira, A., & Pinho, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105280 · Cited by 103 · see citing works
Oxidative and nitrosative stress in the maintenance of myocardial function
Zhang, Y., Tocchetti, C. G., Krieg, T., & Moens, A. L. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.010 · Cited by 96 · see citing works
Self-citationNOXious signaling in pain processing
Kallenborn-Gerhardt, W., Schröder, K., Geißlinger, G., & Schmidtko, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.001 · Cited by 91 · see citing works
Pharmacology and Clinical Drug Candidates in Redox Medicine
Dao, V. T.-V., Casas, A. I., Maghzal, G. J., Seredenina, T., Kaludercic, N., Robledinos-Anton, N., Di Lisa, F., Stocker, R., Ghezzi, P., Jaquet, V., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6430 · Cited by 88 · see citing works
Self-citationReactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 88 · see citing works
Yu, Q., Lee, C. F., Wang, W., Karamanlidis, G., Kuroda, J., Matsushima, S., Sadoshima, J., & Tian, R. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000555 · Cited by 84 · see citing works
Ding, J., Yu, M., Jiang, J., Luo, Y., Zhang, Q., Wang, S., Yang, F., Wang, A., Wang, L., Zhuang, M., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.566410 · Cited by 80 · see citing works
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U. G., & Schmidt, H. H. H. W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.038 · Cited by 77 · see citing works
Self-citationMolecular mechanisms of diabetic retinopathy: Potential therapeutic targets
El‐Remessy, A. B., Coucha, M. M., Elshaer, S. L., Eldahshan, W., & Mysona, B. A. (2015) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.154386 · Cited by 76 · see citing works
NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis
Kato, K., & Hecker, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101541 · Cited by 67 · see citing works
Taïlé, J., Arcambal, A., Clerc, P., Gauvin‐Bialecki, A., & Gonthier, M. (2020) · Antioxidants · doi:10.3390/antiox9070573 · Cited by 67 · see citing works
Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease
Steven, S., Münzel, T. F., & Daiber, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818185 · Cited by 66 · see citing works
VAS2870 is a pan-NADPH oxidase inhibitor
Wingler, K., Altenhöfer, S., Kleikers, P. W. M., Radermacher, K. A., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1107-1 · Cited by 66 · see citing works
Self-citationThe emerging role of NADPH oxidase NOX5 in vascular disease
Jha, J. C., Watson, A. M. D., Mathew, G., de Vos, L. C., & Jandeleit-Dahm, K. A. M. (2017) · Clinical Science · doi:10.1042/cs20160846 · Cited by 58 · see citing works
Boldine Ameliorates Vascular Oxidative Stress and Endothelial Dysfunction
Lau, Y. S., Ling, W. C., Murugan, D. D., & Mustafa, M. R. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000185 · Cited by 60 · see citing works
Tousson, E., Elgharabawy, R. M., & El-Masry, T. A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9434385 · Cited by 58 · see citing works
Antony, S., Wu, Y., Hewitt, S. M., Anver, M. R., Butcher, D. O., Jiang, G., Meitzler, J. L., Liu, H., Juhasz, A. N., Lu, J., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.005 · Cited by 58 · see citing works
Arcambal, A., Taïlé, J., Rondeau, P., Viranaïcken, W., Meilhac, O., & Gonthier, M. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.430 · Cited by 51 · see citing works
Ohata, H., Shiokawa, D., Obata, Y., Sato, A., Sakai, H., Fukami, M., Hara, W., Taniguchi, H., Ono, M., Nakagama, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.085 · Cited by 50 · see citing works
HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women
Kovács, L., Kress, T. C., & de Chantemèle, E. J. B. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.10.017 · Cited by 49 · see citing works
Transforming growth factor‐β1 requires NADPH oxidase 4 for angiogenesisin vitroandin vivo
Peshavariya, H., Chan, E. C., Liu, G., Jiang, F., & Dusting, G. J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12263 · Cited by 49 · see citing works
Nox4-Generated Superoxide Drives Angiotensin II-Induced Neural Stem Cell Proliferation
Topchiy, E., Panzhinskiy, E., Griffin, W. S. T., Barger, S. W., Das, M., & Zawada, W. M. (2013) · Developmental Neuroscience · doi:10.1159/000350502 · Cited by 49 · see citing works
Çekiç, S. D., Çetinkaya, A., Avan, A. N., & Apak, R. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf3051297 · Cited by 49 · see citing works
Reactive oxygen species delay control of lymphocytic choriomeningitis virus
Lang, P. A., Xu, H. C., Grusdat, M., McIlwain, D. R., Pandyra, A. A., Harris, I. S., Shaabani, N., Honke, N., Maney, S. K., Lang, E., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2012.167 · Cited by 51 · see citing works
NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents
Babalola, O., Mamalis, A., Lev‐Tov, H. A., & Jagdeo, J. R. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1416-8 · Cited by 47 · see citing works
González, D. R., Treuer, A. V., Lamirault, G., Mayo, V., Cao, Y., Dulce, R. A., & Hare, J. M. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00890.2013 · Cited by 45 · see citing works
The 1027th target candidate in stroke: Will NADPH oxidase hold up?
Radermacher, K. A., Wingler, K., Kleikers, P. W. M., Altenhöfer, S., Hermans, J. J. R., Kleinschnitz, C., & Schmidt, H. H. H. W. (2012) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-4-11 · Cited by 43 · see citing works
Self-citationBridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors
Cifuentes-Pagano, E., Saha, J., Csányi, G., Ghouleh, I. A., Sahoo, S., Rodriguez, A. I., Wipf, P., Pagano, P. J., & Skoda, E. M. (2013) · MedChemComm · doi:10.1039/c3md00061c · Cited by 39 · see citing works
Wong, P. S., Randall, M. D., & Roberts, R. E. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.04.001 · Cited by 38 · see citing works
Jiao, W., Ji, J., Li, F., Guo, J., Zheng, Y., Li, S., & Xu, W. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9637 · Cited by 37 · see citing works
Samhan-Arias, A. K., & Gutiérrez‐Merino, C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.033 · Cited by 35 · see citing works
Ahmarani, L., Avedanian, L., Al-Khoury, J., Perreault, C., Jacques, D., & Bkaily, G. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0265 · Cited by 34 · see citing works
N-Methyl-D-Aspartate Receptor Signaling and Function in Cardiovascular Tissues
McGee, M. A., & Abdel‐Rahman, A. A. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000398 · Cited by 31 · see citing works
Extracellular Vesicles from Ecklonia cava and Phlorotannin Promote Rejuvenation in Aged Skin
Batsukh, S., Oh, S., Lee, J., Joo, J. H. J., Son, K. H., & Byun, K. (2024) · Marine Drugs · doi:10.3390/md22050223 · Cited by 31 · see citing works
Lu, W., Li, J. Y., Chen, R. J., Huang, L. T., Lee, T. Y., & Lin, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-55189-5 · Cited by 30 · see citing works
Arcambal, A., Taïlé, J., Couret, D., Planesse, C., Veeren, B., Diotel, N., Gauvin‐Bialecki, A., Meilhac, O., & Gonthier, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900779 · Cited by 29 · see citing works
Role of Oxidative Stress and Autophagy in Thoracic Aortic Aneurysms
Irace, L., Cammisotto, V., Valenti, V., Forte, M., Schirone, L., Bartimoccia, S., Iaccarino, A., Peruzzi, M., Schiavon, S., Morelli, A., et al. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.08.002 · Cited by 29 · see citing works
Kumar, A., Ghosh, S. K., Katiyar, R., Gemeda, A. E., Rautela, R., Bisla, A., Srivastava, N., Bhure, S. K., Devi, H. L., & Chandra, V. (2022) · Andrology · doi:10.1111/andr.13158 · Cited by 28 · see citing works
Challenges in vascular tissue engineering for diabetic patients
Dhulekar, J., & Simionescu, A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.01.008 · Cited by 30 · see citing works
Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury
Zhu, T., & Wan, Q. (2022) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2022.06.008 · Cited by 25 · see citing works
Mai, Y., Higashi, T., Terada, K., Hatate, C., Nepal, P., Horiguchi, M., Harada, T., Miwa, S., & Horinouchi, T. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12219sc · Cited by 25 · see citing works
Functional Role of Nox4 in Autophagy
Forte, M., Palmerio, S., Yee, D., Frati, G., & Sciarretta, S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_16 · Cited by 25 · see citing works
NADPH Oxidase Mediates Membrane Androgen Receptor–Induced Neurodegeneration
Tenkorang, M. A. A., Duong, P., & Cunningham, R. L. (2019) · Endocrinology · doi:10.1210/en.2018-01079 · Cited by 26 · see citing works
Zhu, T., Meng, X., Dong, D.-X., Li-yu, Z., Qu, M., Sun, G., & Sun, X. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-1681 · Cited by 24 · see citing works
Kwok, J. M. F., Ma, C. C.-H., & Ma, S. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.10.003 · Cited by 24 · see citing works
Redox Strategies for Crop Improvement
Kerchev, P., Smet, B. D., Waszczak, C., Messens, J., & Breusegem, F. V. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6033 · Cited by 24 · see citing works
Jones, H. S., Gordon, A., Magwenzi, S., Naseem, K., Atkin, S., & Courts, F. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500751 · Cited by 20 · see citing works
Wermuth, P. J., Mendoza, F. A., & Jiménez, S. A. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0161-1 · Cited by 23 · see citing works
An overview of hyperbaric oxygen preconditioning against ischemic stroke
Wu, X., You, J., Chen, X., Zhou, M., Ma, H., Zhang, T., & Huang, C. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01165-y · Cited by 23 · see citing works
Melatonin modifies basal and stimulated insulin secretion via NADPH oxidase
Simões, D., Riva, P., Garcia, R. A. P., Cruzat, V. F., Graciano, M. F. R., Munhoz, A. C., Taneda, M., Cipolla‐Neto, J., & Carpinelli, Â. R. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0259 · Cited by 21 · see citing works
NOX4 Is a Janus-Faced Reactive Oxygen Species Generating NADPH Oxidase
Schmidt, H. H. H. W., Wingler, K., Kleinschnitz, C., & Dusting, G. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.271957 · Cited by 21 · see citing works
Self-citationYang, L., Bai, Y., Li, N., Hu, C.-P., Peng, J., Cheng, G., Zhang, G., & Shi, R. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.012 · Cited by 20 · see citing works
Cheng, D., Tu, W., Chen, L., Wang, H., Wang, Q., Liu, H., Zhu, N., Fang, W., & Yu, Q. (2021) · Aging · doi:10.18632/aging.203569 · Cited by 19 · see citing works
Lipid Peroxidation and Antioxidants in Arterial Hypertension
Sousa, T., Afonso, J., Carvalho, F., & Albino‐Teixeira, A. (2012) · InTech eBooks · doi:10.5772/50346 · Cited by 19 · see citing works
NADPH Oxidase 3: Beyond the Inner Ear
Herb, M. (2024) · Antioxidants · doi:10.3390/antiox13020219 · Cited by 18 · see citing works
Hosseini, A., Stojkov, D., Fettrelet, T., Bilyy, R. O., Yousefi, S., & Simon, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032646 · Cited by 18 · see citing works
Effect of NADPH oxidase inhibitors in an experimental retinal model of excitotoxicity
Dionysopoulou, S., Wikström, P., Walum, E., & Thermos, K. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108232 · Cited by 17 · see citing works
Tarafdar, A., Wolska, N., Krisp, C., Schlüter, H., & Pula, G. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102287 · Cited by 18 · see citing works
Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases
Wang, L., Fang, X., Ling, B., Wang, F., Xia, Y., Zhang, W., Zhong, T., & Wang, X. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1359453 · Cited by 18 · see citing works
Targeting Oxidative Stress in Stroke
Bach, A. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-45345-3_8 · Cited by 15 · see citing works
McGee, M. A., & Abdel‐Rahman, A. A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000059 · Cited by 14 · see citing works
Peptide screen identifies a new NADPH oxidase inhibitor: impact on cell migration and invasion
Mousslim, M., Pagano, A., Andreotti, N., Garrouste, F. L., Thuault, S., Peyrot, V., Parat, F., Luis, J., Culcasi, M., Laurent, S., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.011 · Cited by 14 · see citing works
Fu, Q., Qi, F., Tian, F., Ma, G., Che, F., Du, Y., & Gao, N. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1052877 · Cited by 10 · see citing works
Gutiérrez-González, L. H., Rivas-Fuentes, S., Guzmán‐Beltrán, S., Flores–Flores, A., Rosas-García, J., & Santos-Mendoza, T. (2021) · Molecules · doi:10.3390/molecules26216367 · Cited by 10 · see citing works
Medvedeva, Y. V., Sharman, E. H., & Weiss, J. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-07070-x · Cited by 9 · see citing works
Zhao, R., Le, K., Moghadasian, M. H., & Shen, G. X. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.009 · Cited by 7 · see citing works
The Mechanism of Ferroptosis and Blood–Brain Barrier Damage in Cerebrovascular Diseases
Guo, J., & Yao, C. (2026) · Biomedicines · doi:10.3390/biomedicines14030604 · Cited by 6 · see citing works
Ahluwalia, K., Du, Z., Martinez-Camarillo, J. C., Naik, A. A., Thomas, B. B., Pollalis, D., Lee, S. Y., Dave, P., Zhou, E., Li, Z., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073749 · Cited by 5 · see citing works
The vascular endothelium: still amazing us 30 years on
Garland, C. J., & Weston, A. H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01611.x · Cited by 5 · see citing works
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validationPreprint
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U., & Schmidt, H. H. H. W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/382226 · Cited by 5 · see citing works
Self-citation
- Authors
- Wingler, K., Hermans, J., Schiffers, P., Moens, A., Paul, M., & Schmidt, H.
- Affiliations
- Maastricht University (NL)
- Maastricht University Medical Centre (NL)
- ORCID
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-09-08
- Volume
- 164
- Issue
- 3
- Pages
- 866-883
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC3195911
- OpenAlex
- W1512037315
- Cited by
- 113
- References
- 176
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 8 · 2020: 9 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 7 · 2015: 8 · 2014: 12 · 2013: 15 · 2012: 15
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- ZonMw
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Servier
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- oxidative stress, NADPH oxidase, NOX1, NOX2, NOX4, NADPH oxidase 5, reactive oxygen species, endothelial dysfunction, cardiovascular disease, antioxidant supplementation, soluble guanylate cyclase, NADPH oxidase inhibitors
- MeSH terms
- Animals, Cardiovascular Agents, Cardiovascular Diseases, Humans, Oxidative Stress, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review